Oura
2013 — Founded in Finland
Oura began in Oulu, Finland, founded by Petteri Lahtela, Kari Kivelä, and Markku Koskela. The original idea was simple: use a small wearable to better understand sleep, recovery, and human health. (Oura Ring)
SNR: The company started with a very specific problem rather than trying to build a general-purpose wearable.
2015 — First Oura Ring
The first-generation ring launched in March 2015. Later that year, Oura used Kickstarter to validate demand.
The campaign hit its $100,000 goal in just 15 hours, ultimately generating roughly $650,000 from about 2,400 pre-orders. (Oura Ring)
SNR: Early evidence that consumers were willing to pay for passive health tracking.
2017 — Scientific Validation
Oura received an important credibility boost when researchers at Stanford Research Institute independently tested the ring against clinical sleep measurements.
The study found Oura highly accurate among the wearables tested for sleep quality and sleep stages. (Oura Ring)
SNR: This was a major transition from “interesting gadget” → “scientifically credible health device.”
2017–2019 — Gen 2 & International Expansion
Oura launched Generation 2 in 2017. Sales accelerated, and by August 2019, more than 100,000 Gen 2 rings had been purchased across 100+ countries. (Oura Ring)
The company also raised additional venture capital, including a 2018 round that brought its total funding above $20 million. (TechCrunch)
SNR: Product-market fit began becoming visible.
2020 — COVID Becomes a Catalyst
This was arguably the biggest inflection point in Oura's history.
During COVID, Oura's ability to monitor physiological signals suddenly became much more relevant. More than 65,000 users contributed data to UCSF's TemPredict study, while professional sports organizations—including the NBA—adopted Oura during the pandemic. (Oura Ring)
The NBA's use of Oura in its 2020 bubble brought enormous mainstream visibility. (TechCrunch)
SNR: COVID transformed Oura from a niche sleep product into a potentially important continuous health-monitoring platform.
2021 — Generation 3
Oura launched Gen 3, expanding beyond sleep into a broader set of health measurements and introducing its membership model.
This was an important strategic shift:
Old Oura:
Ring → Sleep tracking
New Oura:
Ring → Continuous data → Subscription → Personalized health insights
(Oura Ring)
SNR: This is where the business model became more interesting than the hardware.
2023–2024 — From Sleep Tracker to Health Platform
Oura began aggressively expanding its capabilities:
- Women's health
- Cycle tracking
- Daytime Stress
- Resilience
- Cardiovascular Age
- Cardio Capacity / VO₂ Max
- Metabolic health
- AI-powered guidance
It also acquired Veri, a metabolic-health company, partnered with Dexcom, and acquired Sparta Science. (Oura Ring)
Then in October 2024, it launched Oura Ring 4, featuring its Smart Sensing technology. (Oura Ring)
SNR: The company was clearly attempting to move from:
Sleep company → comprehensive personal health company.
2024 — $5.2B Valuation
Oura raised $200 million in Series D financing, with participation from Fidelity and Dexcom, bringing its valuation to approximately $5.2 billion. (Oura Ring)
This is important historically because institutional investors were beginning to value Oura as something significantly larger than a wearable startup.
2025 — Major Scale
By September 2025, Oura reported more than 5.5 million rings sold and had doubled revenue for the second consecutive year.
In October 2025, it raised more than $900 million, led by Fidelity, and its reported valuation reached roughly $11 billion. (Oura Ring)
SNR: This is where the growth story became difficult for public markets to ignore.
2026 — Preparing for the Public Markets
Oura began moving toward an IPO, confidentially submitting its draft registration statement in May 2026. (Oura Ring)
By 2026, the company had evolved from a Finnish startup focused primarily on sleep into a global health technology company with members in 150+ countries. It also began the process of moving its legal domicile from Finland to the United States to support its next stage of growth. (Oura Ring)
Oura should not be viewed simply as a smart-ring company. The higher-SNR thesis is that it is attempting to become a recurring-revenue health intelligence platform built around wearable biometric data.
SIGNAL
- ~5.7M paid members
- ~85% 12-month retention
- ~94% of activations converting to paid memberships
- ~$1.2B revenue in 9M FY2026
- Rapid revenue and membership growth
- ~42B hours of biometric data
- Emerging profitability
- Potential data/network effects
- Expansion beyond sleep into broader health monitoring
NOISE
- Celebrity/influencer popularity
- Smart-ring hype
- Generic “AI-powered” claims
- Wearable-market hype
- Healthcare partnerships without proven monetization
- Product/fashion hype
BIGGEST OPPORTUNITY:
Watch whether Oura successfully shifts from a hardware-heavy business toward recurring subscription revenue.
BIGGEST RISK:
The market may already be pricing Oura as a future health-tech platform even though roughly 80% of revenue remains hardware-driven.
SNR INVESTMENT QUESTION
Is Oura becoming a health-data platform faster than the market realizes—or is the market already pricing that future in?
Company quality: ~8.5/10
Growth signal: ~9/10
Data moat: ~9/10
Platform potential: ~9/10
Valuation signal: ~5/10
Bottom Line
Oura = strong business signal, but valuation is the critical variable.
The highest-SNR setup would potentially occur if the market reprices Oura downward while the underlying membership, retention, subscription, and data trends remain strong.